Precision Genomics Collaboratory News

The official list of  Clarivate’s Most Highly Cited Scientists came out on November 15. Among the 30 Duke faculty to make this list, five are also faculty in the Precision Genomics Collaboratory.

Congratulations to our highly cited researchers!

A CRISPR-based platform identified many genes that could potentially improve T-cell therapies for cancer treatment

The North Carolina American Society for Microbiology (NC-ASM) had record attendance at its annual meeting Saturday, hosted by the Duke Microbiome Center, attracting more than 300 researchers from across the Southeast.

Two Duke School of Medicine faculty are among the 25 physician scientists who have received the Paragon Award for Research Excellence from the Doris Duke Foundation.

The Sequencing and Genomics Technologies Core Facility is running orders for the Illumina NovaSeq X Plus.

The X Plus provides high quality short read sequences for a fraction of the cost of the Illumina NovaSeq 6000. Additionally custom read-length projects can now purchase lanes instead of full flow cells (e.g. 75 SR for miRNA-seq, single cell protocols).

The available products are listed below, with more read options available towards the end of the year.

Product

A new internship program aims to alleviate a shortage of African American physicians. North Carolina Central University and Duke University jointly developed the Mentored Internship Program, which allows an undergraduate from NCCU to work as an intern in the division of nephrology at Duke University School of Medicine for one year.

The Duke Clinical and Translational Science Institute (CTSI) recently launched the Center for Precision Health (CPH), the result of a collaboration between CTSI and the Precision Genomics Collaboratory which focuses on how genomic research can transform patient health.

Researchers at Duke University School of Medicine studying multiple sclerosis made an unexpected discovery that could reshape the understanding of MS treatments.

Doug Marchuk and Aravind Asokan have been awarded a three-year $1.9 million grant from the Department of Defense to develop less invasive treatment options for familial cerebral cavernous malformations (CCM).

The Sequencing and Genomic Technologies (SGT) core facility has added two new sequencers to the lab: the PacBio Revio long-read sequencer and the Illumina NovaSeq X Plus short-read sequencer.